Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Q: What does CUSIP 03168L105 represent in this 13F holders report?

CUSIP 03168L105 is the security identifier for AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 used to aggregate holder disclosures.

Q: How many institutions held AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in Q3 2022?

144 institutional investors reported AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 03168L105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Class A Common Stock, par value $0.01
Shares outstanding: 313,041,907
Total 13F shares: 99,522,767
Share change: -27,391
Total reported value: $201,053,119
Put/Call ratio: 47%
Price per share: $2.02
Number of holders: 144
Value change: -$1,681,376
Number of buys: 60
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 03168L105?
CUSIP 03168L105 identifies AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 03168L105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Fosun International Ltd	13F	Company	6.9%	21,521,301	$68,438,000	—	30 Jun 2022	13F
TPG GP A, LLC	13F	Company	5.2%	16,213,367	$51,559,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	4%	12,652,460	$40,236,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	2.4%	7,455,402	$23,708,000	—	30 Jun 2022	13F
Eversept Partners, LP	13F	Company	1.8%	5,494,280	$17,471,810	—	30 Jun 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	3,464,900	$11,018,000	—	30 Jun 2022	13F
Neuberger Berman Group LLC	13F	Company	1%	3,227,892	$10,292,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	0.83%	2,608,362	$8,295,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.58%	1,809,792	$5,756,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.55%	1,731,568	$5,506,000	—	30 Jun 2022	13F
LSV ASSET MANAGEMENT	13F	Company	0.49%	1,532,200	$4,872,000	—	30 Jun 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.49%	1,524,176	$4,847,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.46%	1,433,890	$4,560,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.44%	1,379,476	$4,386,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.37%	1,166,314	$3,709,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.34%	1,050,388	$3,341,000	—	30 Jun 2022	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.32%	987,278	$3,140,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.29%	908,279	$2,888,000	—	30 Jun 2022	13F
Hillsdale Investment Management Inc.	13F	Company	0.28%	861,716	$2,740,000	—	30 Jun 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.26%	825,188	$2,624,000	—	30 Jun 2022	13F
Gustavo Pesquin	3/4/5	Title: Executive Vice President, Chief Commercial Officer - Specialty	— class O/S missing	444,444	$2,537,775	—	06 Sep 2022	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.24%	748,655	$2,381,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.17%	539,330	$1,715,000	—	30 Jun 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.16%	492,288	$1,565,000	—	30 Jun 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.16%	492,300	$1,563,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.15%	462,344	$1,470,000	—	30 Jun 2022	13F
Joseph Todisco	3/4/5	Executive Vice President	— class O/S missing	327,194	$1,350,231	—	07 May 2022	3/4/5
JPMORGAN CHASE & CO	13F	Company	0.12%	374,401	$1,191,000	—	30 Jun 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.11%	334,166	$1,063,000	—	30 Jun 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.1%	326,435	$1,038,000	—	30 Jun 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.09%	292,337	$930,000	—	30 Jun 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	292,283	$929,000	—	30 Jun 2022	13F
Invesco Ltd.	13F	Company	0.08%	264,990	$843,000	—	30 Jun 2022	13F
HRT FINANCIAL LP	13F	Company	0.08%	261,916	$832,000	—	30 Jun 2022	13F
ALGERT GLOBAL LLC	13F	Company	0.08%	237,161	$754,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	0.07%	229,600	$730,000	—	30 Jun 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.07%	204,335	$650,000	—	30 Jun 2022	13F
Brandywine Global Investment Management, LLC	13F	Company	0.06%	197,642	$629,000	—	30 Jun 2022	13F
STRS OHIO	13F	Company	0.06%	194,400	$618,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.06%	188,927	$601,000	—	30 Jun 2022	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.06%	180,000	$572,000	—	30 Jun 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.06%	178,249	$567,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	172,400	$548,000	—	30 Jun 2022	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.05%	165,973	$528,000	—	30 Jun 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	165,694	$527,000	—	30 Jun 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	152,449	$485,000	—	30 Jun 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.05%	151,865	$483,000	—	30 Jun 2022	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.05%	148,707	$473,000	—	30 Jun 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	146,721	$467,000	—	30 Jun 2022	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.05%	146,500	$466,000	—	30 Jun 2022	13F

Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2022

As of 30 Sep 2022, Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,522,767 shares. The largest 10 holders included Fosun International Ltd, TPG GP A, LLC, VANGUARD GROUP INC, BlackRock Inc., Eversept Partners, LP, Neuberger Berman Group LLC, Point72 Asset Management, L.P., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 144 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

140

Q3 2022 holders

144

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.